Uterine Carcinosarcoma — Trials

Uterine Carcinosarcoma — Trials · CancerIndex

Clinical trials

Registered studies

34 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 8
Recruiting: 5
Ph III recruiting: 3
Growth YoY: —
Industry share: 13%
Top sponsor: ARCAGY/ GINECO GROUP
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (7)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05902988	A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer	recruiting	Phase 1 / Phase 2	200	Volastra Therapeutics, Inc.INDUSTRY	1	Nov 4, 2025	clinicaltrials

Data updated 22 days agoSource updated Nov 4, 2025source: clinicaltrials